Showing 1251-1260 of 1633 results for "".
- Daxxify® Surpasses 1 Million Vials Distributed in US Aesthetic Markethttps://modernaesthetics.com/news/daxxify-surpasses-1-million-vials-distributed-in-us-aesthetic-market/2483419/Revance Therapeutics has announced the distribution of more than 1 million vials of daxibotulinumtoxinA-lanm (Daxxify®) for aesthetic use in the United States, marking a notable milestone 3 years after the product received US Food and Drug Administration (FDA) approval. According to a pres
- Hugel Marks 15 Years of Letybo with 2025 H.E.L.F Symposium in Seoulhttps://modernaesthetics.com/news/hugel-marks-15-years-of-letybo-with-2025-helf-symposium-in-seoul/2483385/More than 220 medical professionals from across the globe gathered in Seoul on September 14 for Hugel Inc.’s 2025 H.E.L.F. symposium, marking 15 years since the launch of its botulinum toxin, Letybo. The Hugel Expert Leader’s Forum was held at Seoul Dragon City under the theme, “K-Beau
- Study Finds Abdominoplasty Can Help Improve Urinary Incontinence Symptomshttps://modernaesthetics.com/news/study-finds-abdominoplasty-can-help-improve-urinary-incontinence-symptoms/2483374/A new study published in Aesthetic Plastic Surgery reports that abdominoplasty may contribute to improvement in urinary incontinence symptoms. The study titled “Can Abdominoplasty Relieve Symptoms of Urinary Incontinence?” systematically reviewed the existing literature to evaluate the f
- New HA Filler Obagi® saypha® MagIQ™ Approved by FDAhttps://modernaesthetics.com/news/new-ha-filler-obagi-saypha-magiq-approved-by-fda/2483329/The US Food and Drug Administration (FDA) has approved Obagi® saypha® MagIQ™, an injectable hyaluronic acid (HA) gel, marking the first product in the Obagi® saypha® collection under the Obagi Medical brand, Waldencast plc announced.
- Thermage® FLX Exceeds 5 Million Skin Tightening Treatmentshttps://modernaesthetics.com/news/thermage-flx-exceeds-5-million-skin-tightening-treatments/2483284/Solta Medical, a subsidiary of Bausch Health Companies Inc., announced that more than 5 million Thermage® treatments have been performed worldwide, underscoring the global uptake of its skin tightening technology. Thermage® uses monopolar radiofrequency energy to heat skin layers and stimu
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- JUVÉDERM Day Returns with Limited-Time Offers Through Rewards Programhttps://modernaesthetics.com/news/juvederm-day-returns-limited-time-offers-through-rewards-program/2482957/Members of JUVÉDERM’s Alle loyalty rewards program will have an opportunity to purchase “buy one, get one” gift cards as part of JUVÉDERM Day on August 20, according to Allergan Aesthetics, an AbbVie company. Details of the exclusive, limited limited-time offers are as follows: •
- TOPICAL SKIN Launches Antioxidant Face Oilhttps://modernaesthetics.com/news/topical-skin-launches-antioxidant-face-oil/2476145/Skincare brand TOPICAL SKIN launched Phyto AOX Face Oil N°10, a plant-based facial oil developed to protect the skin from environmental damage such as pollution, UV rays, and blue light. The formula features a proprietary Exposome Defense Technology, describ
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers